
### [MONDO:0019710](http://purl.obolibrary.org/obo/MONDO_0019710)
**Label:** dysostosis with predominant craniofacial involvement

**Subclasses:** [MONDO:0016643](http://purl.obolibrary.org/obo/MONDO_0016643) (frontonasal dysplasia), [MONDO:0011255](http://purl.obolibrary.org/obo/MONDO_0011255) (mandibulofacial dysostosis-macroblepharon-macrostomia syndrome), [MONDO:0013271](http://purl.obolibrary.org/obo/MONDO_0013271) (frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome), [MONDO:0002457](http://purl.obolibrary.org/obo/MONDO_0002457) (Treacher-Collins syndrome), [MONDO:0009558](http://purl.obolibrary.org/obo/MONDO_0009558) (Treacher Collins syndrome 3), [MONDO:0007944](http://purl.obolibrary.org/obo/MONDO_0007944) (Treacher-Collins syndrome 1), [MONDO:0014608](http://purl.obolibrary.org/obo/MONDO_0014608) (mandibulofacial dysostosis with alopecia), [MONDO:0014824](http://purl.obolibrary.org/obo/MONDO_0014824) (craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome), [MONDO:0007780](http://purl.obolibrary.org/obo/MONDO_0007780) (hypertelorism, Teebi type), [MONDO:0010101](http://purl.obolibrary.org/obo/MONDO_0010101) (Teebi-Shaltout syndrome), [MONDO:0011359](http://purl.obolibrary.org/obo/MONDO_0011359) (acromelic frontonasal dysostosis), [MONDO:0013268](http://purl.obolibrary.org/obo/MONDO_0013268) (frontonasal dysplasia with alopecia and genital anomaly), [MONDO:0010570](http://purl.obolibrary.org/obo/MONDO_0010570) (craniofrontonasal syndrome), [MONDO:0015464](http://purl.obolibrary.org/obo/MONDO_0015464) (craniofrontonasal dysplasia-Poland anomaly syndrome), [MONDO:0017980](http://purl.obolibrary.org/obo/MONDO_0017980) (syngnathia multiple anomalies), [MONDO:0008112](http://purl.obolibrary.org/obo/MONDO_0008112) (Goldenhar syndrome), [MONDO:0013385](http://purl.obolibrary.org/obo/MONDO_0013385) (Treacher Collins syndrome 2), [MONDO:0009247](http://purl.obolibrary.org/obo/MONDO_0009247) (Frontofacionasal dysplasia), [MONDO:0011082](http://purl.obolibrary.org/obo/MONDO_0011082) (Oculoauriculofrontonasal syndrome), [MONDO:0009801](http://purl.obolibrary.org/obo/MONDO_0009801) (familial osteodysplasia, Anderson type), [MONDO:0009406](http://purl.obolibrary.org/obo/MONDO_0009406) (hypertrichotic osteochondrodysplasia Cantu type), [MONDO:0007956](http://purl.obolibrary.org/obo/MONDO_0007956) (Pai syndrome), [MONDO:0007636](http://purl.obolibrary.org/obo/MONDO_0007636) (Frontorhiny), [MONDO:0007712](http://purl.obolibrary.org/obo/MONDO_0007712) (Oculoauriculovertebral spectrum with radial defects), [MONDO:0007259](http://purl.obolibrary.org/obo/MONDO_0007259) (craniofaciofrontodigital syndrome), [MONDO:0010850](http://purl.obolibrary.org/obo/MONDO_0010850) (Tessier number 4 facial cleft), [MONDO:0015824](http://purl.obolibrary.org/obo/MONDO_0015824) (oculomaxillofacial dysostosis), 

**Mapped go classes:** [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0097095](http://purl.obolibrary.org/obo/GO_0097095) (frontonasal suture morphogenesis), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0017183](http://purl.obolibrary.org/obo/GO_0017183) (peptidyl-diphthamide biosynthetic process from peptidyl-histidine), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:1990402](http://purl.obolibrary.org/obo/GO_1990402) (embryonic liver development), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:0007026](http://purl.obolibrary.org/obo/GO_0007026) (negative regulation of microtubule depolymerization), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001042](http://purl.obolibrary.org/obo/GO_0001042) (RNA polymerase I core binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0042790](http://purl.obolibrary.org/obo/GO_0042790) (transcription of nucleolar large rRNA by RNA polymerase I), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0048812](http://purl.obolibrary.org/obo/GO_0048812) (neuron projection morphogenesis), [GO:0046875](http://purl.obolibrary.org/obo/GO_0046875) (ephrin receptor binding), [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0006417](http://purl.obolibrary.org/obo/GO_0006417) (regulation of translation), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0032420](http://purl.obolibrary.org/obo/GO_0032420) (stereocilium), [GO:2001222](http://purl.obolibrary.org/obo/GO_2001222) (regulation of neuron migration), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0031295](http://purl.obolibrary.org/obo/GO_0031295) (T cell costimulation), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0005736](http://purl.obolibrary.org/obo/GO_0005736) (DNA-directed RNA polymerase I complex), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0003319](http://purl.obolibrary.org/obo/GO_0003319) (cardioblast migration to the midline involved in heart rudiment formation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0015630](http://purl.obolibrary.org/obo/GO_0015630) (microtubule cytoskeleton), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0003404](http://purl.obolibrary.org/obo/GO_0003404) (optic vesicle morphogenesis), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0015629](http://purl.obolibrary.org/obo/GO_0015629) (actin cytoskeleton), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0035115](http://purl.obolibrary.org/obo/GO_0035115) (embryonic forelimb morphogenesis), [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0014031](http://purl.obolibrary.org/obo/GO_0014031) (mesenchymal cell development), [GO:0009880](http://purl.obolibrary.org/obo/GO_0009880) (embryonic pattern specification), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0003899](http://purl.obolibrary.org/obo/GO_0003899) (DNA-directed 5'-3' RNA polymerase activity), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0031941](http://purl.obolibrary.org/obo/GO_0031941) (filamentous actin), [GO:0014029](http://purl.obolibrary.org/obo/GO_0014029) (neural crest formation), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0004962](http://purl.obolibrary.org/obo/GO_0004962) (endothelin receptor activity), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0010718](http://purl.obolibrary.org/obo/GO_0010718) (positive regulation of epithelial to mesenchymal transition), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005921](http://purl.obolibrary.org/obo/GO_0005921) (gap junction), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0001056](http://purl.obolibrary.org/obo/GO_0001056) (RNA polymerase III activity), [GO:0001054](http://purl.obolibrary.org/obo/GO_0001054) (RNA polymerase I activity), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0010155](http://purl.obolibrary.org/obo/GO_0010155) (regulation of proton transport), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005267](http://purl.obolibrary.org/obo/GO_0005267) (potassium channel activity), [GO:0005666](http://purl.obolibrary.org/obo/GO_0005666) (DNA-directed RNA polymerase III complex), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0030835](http://purl.obolibrary.org/obo/GO_0030835) (negative regulation of actin filament depolymerization), [GO:0005815](http://purl.obolibrary.org/obo/GO_0005815) (microtubule organizing center), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0005819](http://purl.obolibrary.org/obo/GO_0005819) (spindle), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), 

**Class expressions from DL-Learner:**

- Thing 54.04%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.25%
- [GO:0015630](http://purl.obolibrary.org/obo/GO_0015630) (microtubule cytoskeleton) 51.25%
- [GO:0005921](http://purl.obolibrary.org/obo/GO_0005921) (gap junction) 51.25%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 51.25%
- [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus) 51.25%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.61%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004291](http://purl.obolibrary.org/obo/GO_0004291) (obsolete subtilisin activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004290](http://purl.obolibrary.org/obo/GO_0004290) (obsolete kexin activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004289](http://purl.obolibrary.org/obo/GO_0004289) (obsolete subtilase activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004287](http://purl.obolibrary.org/obo/GO_0004287) (obsolete prolyl oligopeptidase activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004286](http://purl.obolibrary.org/obo/GO_0004286) (obsolete proprotein convertase 2 activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004285](http://purl.obolibrary.org/obo/GO_0004285) (obsolete proprotein convertase 1 activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004284](http://purl.obolibrary.org/obo/GO_0004284) (obsolete acrosin activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.61%


